# Penehyclidine for Prevention of Nausea and Vomiting After Bimaxillary Surgery

> **NCT04454866** · NA · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 354 (actual)

## Conditions studied

- Penehyclidine
- Postoperative Nausea and Vomiting
- Bimaxillar Surgery

## Interventions

- **DRUG:** Single injection of penehyclidine
- **DRUG:** Continuous infusion of penehyclidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04454866
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-07
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-04-15
- **Target enrollment:** 354 (ACTUAL)
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04454866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04454866, "Penehyclidine for Prevention of Nausea and Vomiting After Bimaxillary Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04454866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*